Kevin K Buckbee sold $3.9M of ABBV
SVP, CONTROLLER at AbbVie Inc.. 18,944 shares at an average of $203.41, traded Feb 26, 2025, filed Feb 28, 2025.
Score components
- +15RoleOfficer
- +25Trade size$3.9M at market
- +20Share of holdings soldSold 100% of holdings
- +15Cluster4 insiders selling within 14 days
- +10Role exitThe filing reports the insider leaving
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001415889-25-006025, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 26, 2025 | SOpen-market sale Common Stock, $0.01 par value | -2,684 | $203.40 | $546k | 12,646 | Feb 28, 2025 |
| Feb 26, 2025 | MOption exercise Common Stock, $0.01 par value | +9,738 | $93.50 | $911k | 22,384 | Feb 28, 2025 |
| Feb 26, 2025 | MOption exercise Common Stock, $0.01 par value | +6,522 | $105.92 | $691k | 28,906 | Feb 28, 2025 |
| Feb 26, 2025 | SOpen-market sale Common Stock, $0.01 par value | -16,260 | $203.41 | $3.3M | 11,496 | Feb 28, 2025 |
| Feb 26, 2025 | MOption exercise Option (Right to buy)derivative | -9,738 | $93.50 | $911k | 2,373 | Feb 28, 2025 |
| Feb 26, 2025 | MOption exercise Option (Right to buy)derivative | -6,522 | $105.92 | $691k | 2,794 | Feb 28, 2025 |
Related signals
Other insiders at AbbVie Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 43Moderate | AbbVie Inc. | Azita Saleki-Gerhardt EVP, CHIEF OPERATIONS OFFICER | $8.4M 42,370 shares | -19% | |
| 53Moderate | AbbVie Inc. | Nicholas Donoghoe EVP, CHIEF BUS/STRAT OFFICER | $2.6M 13,295 shares | -19% | |
| 45Moderate | ABBVsell AbbVie Inc. | Jeffrey Ryan Stewart EVP, CHIEF COMMERCIAL OFFICER | $12M 58,832 shares | -52% | |
| 82Strong | AbbVie Inc. | Scott T Reents EVP, CHIEF FINANCIAL OFFICER | $3.7M 17,644 shares | -60% | |
| 40Moderate | AbbVie Inc. | Perry C Siatis EVP, GC AND SECRETARY | $5.8M 27,900 shares | -192% | |
| 60Notable | AbbVie Inc. | Richard A Gonzalez director | $20M 98,628 shares | -20% | |
| 55Moderate | AbbVie Inc. | Timothy J. Richmond EVP, CHIEF HR OFFICER | $4.5M 21,250 shares | -78% | |
| 40Moderate | AbbVie Inc. | Timothy J. Richmond EVP, CHIEF HR OFFICER | $6.1M 29,917 shares | -58% | |
| 40Moderate | AbbVie Inc. | Perry C Siatis EVP, GC AND SECRETARY | $1.1M 5,778 shares | -21% | |
| 19Weak | ABBVsell AbbVie Inc. | Kevin K Buckbee SVP, CONTROLLER | $310k 1,800 shares | -20% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.